Objective Health

About Objective Health

Objective Health operates as an integrated clinical research and technology services platform, founded in 2018 by Don Lazas, MD, and Colleen Hoke. Initially established as ObjectiveGI with a focus on gastrointestinal (GI) research, the company rebranded to ObjectiveHealth in September 2021 to reflect its expansion into broader therapeutic areas. The founding vision, driven by Dr. Lazas, a gastroenterologist, and Hoke, a research executive, was to embed clinical research as a care option directly at the point of care.

The company's business model centers on forming partnerships with physician practices, community health centers, and healthcare organizations to establish an advanced infrastructure for conducting clinical research. This approach provides a natural extension of patient care, offering trial access within the local community. Objective Health's clients include pharmaceutical companies and contract research organizations (CROs) that benefit from improved patient recruitment and high-quality data. The company's revenue is generated by providing these integrated research services. The firm has secured significant funding, including a Series A round in January 2024 led by Vitruvian Partners, to fuel its expansion.

Objective Health's core service is the seamless integration of clinical trials into physician practices. This is powered by proprietary AI-driven technology, including a platform named 'ObjectiveScreen', which analyzes electronic health record (EHR) data to identify and pre-qualify suitable patient candidates for specific trials. The company also offers 'ObjectiveView', a portal that gives trial sponsors transparency into the research process. By placing trained on-site personnel within partner practices, Objective Health manages study implementation, patient matching, and data quality, which helps accelerate trial execution. Initially focused on prevalent GI diseases like NASH and fatty liver disease, the company has broadened its research portfolio to include dermatology, urology, oncology, and metabolic disorders.